• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Targeted indoor residual spraying (IRS) is non-inferior to standard IRS for malaria control in low-transmission settings

byConstance Wu
March 16, 2021
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Targeted IRS was non-inferior to standard IRS with respect to malaria incidence (1.05 cases per 1000 person-years vs. 0.95 cases per 1000 person-years).

2. Targeted IRS was more cost-effective and saved $7845 USD per additional DALY incurred. 

Evidence Rating Level: 1 (Excellent)

Study Rundown: Since 2017, global malaria funding has remained well below WHO’s $5.6 billion per year target. Increasing insecticide costs and constrained budgets have called for more efficient strategies to reduce malaria transmission. One such strategy is targeted indoor residual spraying (IRS) in which only houses of index cases and immediate neighbors are sprayed. This is in contrast to standard IRS which comprises annual mass spray campaigns in areas using historical data. This study aimed to evaluate the effectiveness of reactive, targeted IRS versus standard IRS in northeastern South Africa. The primary endpoint was malaria incidence, while secondary endpoints included household compliance, attitudes to IRS, and serological markers. According to study results, targeted IRS demonstrated non-inferior malaria incidence across the two-year period compared to the standard IRS group. Additionally, targeted IRS yielded a much greater cost benefit per additional disability adjusted life-year (DALY) incurred. A weakness of this study was that households from only three districts in northeastern South Africa were included. Given that these regions are known to have a low viral transmission, the incidence of malaria was likely underreported. Nevertheless, this study sheds light onto the non-inferior nature of targeted IRS compared to standard IRS in this very-low transmission setting.

Click to read the study in The Lancet

Relevant Reading: Evaluating the impact of screening plus eave tubes on malaria transmission compared to current best practice in central Côte d’Ivoire: a two armed cluster randomized controlled trial

In-depth [randomized controlled trial]: This study took place between Aug 1, 2015, and July 31, 2017, in the rural subdistricts of Bushbuckridge in Mpumalanga province and Ba-Phalaborwa in Limpopo province. Clusters comprising 5000-10 000 people were formed using census wards. Included clusters had ≥ 1 year history of local cases in the last 5 years before the trial. Altogether, 400 000 people resided within trial clusters with the majority (72%) belonging to the province of Mpumalanga. A non-inferiority margin of 1 case per 1000 person-years was selected.

RELATED REPORTS

Monoclonal antibody CIS43LS efficacious in preventing malaria in Mali

Monoclonal antibody L9LS prevents malaria infection in adults

Higher-dose primaquine has higher efficacy in preventing relapse of Plasmodium vivax malaria

During the 2-year trial period, 1030 cases of malaria were detected, of which 705 (68%) were classified as local. The annual incidence of cases was 0.05 per 1000 person-years (n=20) in year 1 and 1.74 per 1000 person-years (n=685) in year 2. The primary endpoint of malaria incidence showed non-inferiority between the targeted IRS group (1.05 per 1000 person-years, 95% confidence interval [CI] 0.72-1.38, n=394) compared to the standard IRS group (0.95 per 1000 person-years, 95% CI 0.58-1.32, n=311), with a rate difference of 0.10 (95% CI -0.38 to 0.59) or one extra case per 10 000 people in the targeted IRS group. In terms of cost-effectiveness, the average annual economic cost was $88 258 per 100 000 population for targeted IRS. This is 52% less than the cost for standard IRS ($184 319). Targeted IRS was more cost-effective as it involved spraying fewer structures, did not use contract sprayers, and used substantially less insecticide, transport, and equipment. Across the trial period, targeted IRS saved $7845 (95% CI 2902-64 907) for each additional DALY incurred related to standard IRS. There were 21 deaths altogether, 12 in the standard IRS group and 9 in the targeted IRS group. No other serious adverse events were reported. Overall, findings from this study suggest that targeted IRS was non-inferior, safe, and cost-effective compared with standard IRS. Saved resources could be reallocated to other malaria control strategies.

Tags: indoor residual sprayingmalariatargeted indoor residual spraying
Previous Post

South European Atlantic Diet associated with lower all-cause mortality

Next Post

Maternal folic acid supplementation associated with stronger child cognitive performance at 11 years of age

RelatedReports

RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time
Infectious Disease

Monoclonal antibody CIS43LS efficacious in preventing malaria in Mali

November 23, 2022
Intrauterine Zika virus infection associated with significant fetal brain abnormalities
Chronic Disease

Monoclonal antibody L9LS prevents malaria infection in adults

August 11, 2022
RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time
Chronic Disease

Higher-dose primaquine has higher efficacy in preventing relapse of Plasmodium vivax malaria

April 22, 2022
RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time
Infectious Disease

Chlorfenapyr insecticidal nets provide strong protection against malaria in sub-Saharan Africa

April 6, 2022
Next Post
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Maternal folic acid supplementation associated with stronger child cognitive performance at 11 years of age

Influenza vaccine not associated with increased risk of epilepsy in children

ChAdOx1-nCoV-19 vaccine maintains efficacy despite a longer prime-boost interval

Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia

PICU admissions due to bronchiolitis markedly reduced during COVID-19 pandemic

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options